225 related articles for article (PubMed ID: 21656826)
21. Docetaxel-induced apoptosis of human melanoma is mediated by activation of c-Jun NH2-terminal kinase and inhibited by the mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway.
Mhaidat NM; Zhang XD; Jiang CC; Hersey P
Clin Cancer Res; 2007 Feb; 13(4):1308-14. PubMed ID: 17317842
[TBL] [Abstract][Full Text] [Related]
22. Differential phosphoprotein levels and pathway analysis identify the transition mechanism of LNCaP cells into androgen-independent cells.
Wang HQ; Yang B; Xu CL; Wang LH; Zhang YX; Xu B; Ji JT; Sun YH
Prostate; 2010 Apr; 70(5):508-17. PubMed ID: 19937597
[TBL] [Abstract][Full Text] [Related]
23. PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells.
Kadowaki Y; Chari NS; Teo AE; Hashi A; Spurgers KB; McDonnell TJ
Apoptosis; 2011 Jun; 16(6):627-35. PubMed ID: 21437722
[TBL] [Abstract][Full Text] [Related]
24. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
[TBL] [Abstract][Full Text] [Related]
25. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
An J; Chervin AS; Nie A; Ducoff HS; Huang Z
Oncogene; 2007 Feb; 26(5):652-61. PubMed ID: 16909121
[TBL] [Abstract][Full Text] [Related]
26. Busulfan selectively induces cellular senescence but not apoptosis in WI38 fibroblasts via a p53-independent but extracellular signal-regulated kinase-p38 mitogen-activated protein kinase-dependent mechanism.
Probin V; Wang Y; Bai A; Zhou D
J Pharmacol Exp Ther; 2006 Nov; 319(2):551-60. PubMed ID: 16882877
[TBL] [Abstract][Full Text] [Related]
27. The p38 MAPK pathway mediates aryl propionic acid induced messenger rna stability of p75 NTR in prostate cancer cells.
Quann EJ; Khwaja F; Djakiew D
Cancer Res; 2007 Dec; 67(23):11402-10. PubMed ID: 18056468
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
Domingo-Domenech J; Oliva C; Rovira A; Codony-Servat J; Bosch M; Filella X; Montagut C; Tapia M; Campás C; Dang L; Rolfe M; Ross JS; Gascon P; Albanell J; Mellado B
Clin Cancer Res; 2006 Sep; 12(18):5578-86. PubMed ID: 17000695
[TBL] [Abstract][Full Text] [Related]
29. Anticancer effect of docetaxel induces apoptosis of prostate cancer via the cofilin-1 and paxillin signaling pathway.
Xiao P; Ma T; Zhou C; Xu Y; Liu Y; Zhang H
Mol Med Rep; 2016 May; 13(5):4079-84. PubMed ID: 27035282
[TBL] [Abstract][Full Text] [Related]
30. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
[TBL] [Abstract][Full Text] [Related]
31. Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.
Choi MS; Oh JH; Kim SM; Jung HY; Yoo HS; Lee YM; Moon DC; Han SB; Hong JT
Int J Oncol; 2009 May; 34(5):1221-30. PubMed ID: 19360335
[TBL] [Abstract][Full Text] [Related]
32. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
Qiu J; Gao Z; Shima H
Oncol Rep; 2012 Jan; 27(1):160-7. PubMed ID: 21947091
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Ca2+-independent phospholipase A2 decreases prostate cancer cell growth by p53-dependent and independent mechanisms.
Sun B; Zhang X; Talathi S; Cummings BS
J Pharmacol Exp Ther; 2008 Jul; 326(1):59-68. PubMed ID: 18441250
[TBL] [Abstract][Full Text] [Related]
34. Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells.
Jiao JW; Wen F
Oncol Rep; 2011 Mar; 25(3):781-8. PubMed ID: 21165580
[TBL] [Abstract][Full Text] [Related]
35. 3,3'-diindolylmethane induction of p75NTR-dependent cell death via the p38 mitogen-activated protein kinase pathway in prostate cancer cells.
Khwaja FS; Wynne S; Posey I; Djakiew D
Cancer Prev Res (Phila); 2009 Jun; 2(6):566-71. PubMed ID: 19470787
[TBL] [Abstract][Full Text] [Related]
36. ABCC4 Decreases docetaxel and not cabazitaxel efficacy in prostate cancer cells in vitro.
Oprea-Lager DE; Bijnsdorp IV; VAN Moorselaar RJ; VAN DEN Eertwegh AJ; Hoekstra OS; Geldof AA
Anticancer Res; 2013 Feb; 33(2):387-91. PubMed ID: 23393328
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the response of prostate cancer cell lines to cisplatin treatment using small interfering RNA.
Parra E; Ferreira J
Oncol Rep; 2013 Oct; 30(4):1936-42. PubMed ID: 23900581
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cells.
Li H; Qi Y; Li C; Braseth LN; Gao Y; Shabashvili AE; Katovich MJ; Sumners C
Mol Cancer Ther; 2009 Dec; 8(12):3255-65. PubMed ID: 19996275
[TBL] [Abstract][Full Text] [Related]
39. Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells.
Xing H; Weng D; Chen G; Tao W; Zhu T; Yang X; Meng L; Wang S; Lu Y; Ma D
Cancer Lett; 2008 Mar; 261(1):108-19. PubMed ID: 18171600
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of p21-activated kinase 6 inhibits prostate cancer growth and enhances chemosensitivity to docetaxel.
Wen X; Li X; Liao B; Liu Y; Wu J; Yuan X; Ouyang B; Sun Q; Gao X
Urology; 2009 Jun; 73(6):1407-11. PubMed ID: 19362342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
